Sarcosine-13C

Stable Isotopes API Family: Sarcosine CAT No. CS-T-96875 CAS No. 1173018-85-3
Enquire
Product Detail

Sarcosine-13C

Sarcosine Stable Isotopes
Stock Status: Enquire
Live
For Research & Analytical Purposes. Not for Personal use.
Category Stable Isotopes
API Family Sarcosine
Storage Refer MSDS for complete information.
Hazard Information Refer MSDS for complete information.

Sarcosine-13C Product Information

Sarcosine-13C is listed under Stable Isotopes. It is associated with Sarcosine and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-96875.

Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.

Technical Data

Product Name
Sarcosine-13C
CAS No.
1173018-85-3
CAT No.
CS-T-96875
Molecular Formula
C2ยนยณCH7NO2
Molecular Weight
90.09
Category
API Family
Storage Condition
Refer MSDS for complete information.
SMILES
OC(CN[13CH3])=O
IUPAC Name
Sarcosine-13C
Hazard Compound
Refer MSDS for complete information.

Description

Overview
"Sarcosine-13C is an isotope labelled compound of Sarcosine (S140500). Sarcosine is a typeย 1 glycine transporter inhibitor and a glycine agonist that may be useful for treating schizophrenia. Also, used in the study of the potential therapeutic efficacy of glycine transporter 1 inhibitors in the treatment of central nervous system disorders in human system."
Synonyms
N-Methylglycine-13C; (Methylamino)acetic Acid-13C; (Methylamino)ethanoic Acid-13C; N-Methylglycocoll-13C; Methylglycine-13C; Sarcosin-13C; Sarcosinic Acid-13C; Sar-13C;
Application Notes
"Sarcosine-13C is an isotope labelled compound of Sarcosine (S140500). Sarcosine is a typeย 1 glycine transporter inhibitor and a glycine agonist that may be useful for treating schizophrenia. Also, used in the study of the potential therapeutic efficacy of glycine transporter 1 inhibitors in the treatment of central nervous system disorders in human system."
References
"Cioffi, C. L., et al.: Curr. Top. Med. Chem. (Sharjah, United Arab Emirates), 16, 3404 (2016); Strzelecki, D., et al.: Int. J. Mol. Sci., 16, 24475 (2015)"
Downloading MSDSโ€ฆ
Done
Done
RFQ Basket 0
Done
RFQ Basket 0
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.